Enavate Sciences GP, LLC

13F Portfolio Filings

  • Most recent 13F
    Q1 2025
  • Location
    new york, NY
  • CIK
    0001953107
  • All SEC filings
Q1 2025
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

6

$132.72M
IMNM, ZENAS BIOPHARMA INC, SIONNA THERAPEUTICS INC, CAMP4 THERAPEUTICS CORP
13F-HR
May 15, 2025
000141588925013132

5

$139.24M
UPSTREAM BIO INC, IMNM, ZENAS BIOPHARMA INC, CAMP4 THERAPEUTICS CORP
13F-HR
Feb 14, 2025
000110465925014094